news

MENLO PARK, Calif.–(BUSINESS WIRE)–Bluestar Adisseo Company (Adisseo), a world leader in feed additives for animal nutrition, and the world’s leading

Presenting Ten Research Studies using the Cancer Transcriptome Atlas to Discover Novel Biomarkers and First Data from Forthcoming Whole Transcriptome

SAN DIEGO–(BUSINESS WIRE)–#bio—Calidi Biotherapeutics, Inc. (“Calidi”), a clinical‐stage biotechnology company at the forefront of oncolytic virus-based immunotherapies for cancer, today

GSK to obtain access to two Immatics TCR-T programs, further advancing their commitment to the field of cell therapies Immatics

LONDON & BOSTON & TOKYO–(BUSINESS WIRE)–#biopharma–Stock market gains and dealmaking activity in Q4 clinched the biopharma sector’s strong performance in

Results from Phase 2 study published in the New England Journal of Medicine. Nemolizumab met the primary endpoint of a

TORONTO–(BUSINESS WIRE)–#FSDDF—FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) (“FSD Pharma” or the “Company”) today announced the sale of

Partnership brings together Vifor Pharma’s world-class iron deficiency portfolio with Fresenius Kabi’s market-leading patient access in China Gives Vifor Pharma

– Liposomal Cyclosporine A for Inhalation (L‑CsA‑i) is advancing in clinical studies for the treatment for bronchiolitis obliterans syndrome (BOS)

– Proceeds to advance development of Tildacerfont in Congenital Adrenal Hyperplasia and other indications – Existing Investors Novo Holdings and